Last checked at 14 Apr 2023 07:00
14 April 2023
SkinBioTherapeutics plc
("SBTX" or the "Company")
Director Bed & ISA Dealings
SkinBioTherapeutics plc (AIM: SBTX), the life science company focused on skin health, announces that it received notification on 13 April 2023 of the following PDMR transactions:
Stuart Ashman, CEO and PDMR, sold 123,878 ordinary shares of 1p each in the Company ("Ordinary Shares") and repurchased 122,517 Ordinary Shares into Mr Ashman's ISA account. Following this transaction Stuart Ashman's beneficial interest in the Company shares has reduced by 1,361 ordinary shares.
In addition, Manprit Randhawa, CFO and PDMR, sold 66,778 Ordinary Shares and repurchased 66,778 Ordinary Shares into Mr Randhawa's ISA account. Following this transaction Manprit Randhawa's beneficial interest in the Company shares has not changed.
Details of PDMR transactions
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Stuart Ashman | |||
2 | Reason for the notification | ||||
a) | Position/status | PDMR (CEO) | |||
b) | Initial notification /Amendment | Initial notification | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | SkinBioTherapeutics plc | |||
b) | LEI | 213800YMQOCB23FX6I06 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares in SkinBioTherapeutics plc | |||
Identification code | GB00BF33H870 | ||||
b) | Nature of the transaction | Sale and purchase of ordinary shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
Sale at 16.25 p | 123,878 | ||||
Purchase at 16.25 p | 122,517 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | n/a | ||||
- Price | |||||
e) | Date of the transactions | 6 April 2023 | |||
f) | Place of the transaction | London Stock Exchange | |||
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Manprit Randhawa | |||
2 | Reason for the notification | ||||
a) | Position/status | PDMR (CFO) | |||
b) | Initial notification /Amendment | Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | SkinBioTherapeutics plc | |||
b) | LEI | 213800YMQOCB23FX6I06 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares in SkinBioTherapeutics plc | |||
Identification code | GB00BF33H870 | ||||
b) | Nature of the transaction | Sale and purchase of ordinary shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
Sale at 16.00 p | 66,778 | ||||
Purchase at 16.03 p | 66,778 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | n/a | ||||
- Price | |||||
e) | Date of the transactions | 6 April 2023 | |||
f) | Place of the transaction | London Stock Exchange | |||